SUBSCRIBE
SUBSCRIBE
News   Policy

IsoRay, Inc. Receives No List of Observations (Form FDA 483) in FDA Inspection

July 24, 2008 | 
1 min read
RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (AMEX:ISR) announced today the completion of a baseline inspection by the Food and Drug Administration (FDA) for all its Quality Systems.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
A cartoon of a scientist standing in a laboratory, next to a microscope and flasks
Government
100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts
June 30, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA
FDA’s AI Rollout Raises Questions Around Readiness, Legality
June 30, 2025
 · 
6 min read
 · 
Natalia Mesa
Facade of the FDA's office in Maryland
Approvals
Moderna, Merck, UroGen, Score RSV and Cancer Nods in June
June 30, 2025
 · 
9 min read
 · 
Tristan Manalac
Themis with sword and scales in cyberspace. Ai regulation, artificial intelligence and law issues concept. Vector illustration.
Legal
Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force
June 27, 2025
 · 
2 min read
 · 
Annalee Armstrong